TOPIC : Alternative production system to address anti-microbial drug usage, animal welfare and the impact on health
|Publication date:||14 October 2015|
|Types of action:||RIA Research and Innovation action|
|DeadlineModel: Opening date:||two-stage 04 October 2016||Deadline: 2nd stage Deadline:||
14 February 2017 17:00:00
13 September 2017 17:00:00
|Time Zone : (Brussels time)|
14 June 2017 11:42
The generalised feedback, resulting after the 1st stage evaluation of this topic, is published on this page. To download the document, just expand the "Topic conditions and documents" area (i.e. click on '+ More'), scroll down until "Additional documents" and the generalised feedback can be downloaded in pdf.
24 May 2017 16:01
Letters informing on the results of the evaluation are being sent to applicants.
Under the tab 'Topic conditions and documents' the following document is available in section 8. "Additional documents":
◦An overview of the evaluation results (Flash Call Information);
11 January 2017 16:27
As of 1st January 2017, Switzerland is associated to the whole Horizon 2020 programme instead of the previous partial association. More information on this matter can be found here.
Topic DescriptionSpecific Challenge:
Confined systems dominate in modern livestock production worldwide, in particular as regards monogastric species. These systems often constrain natural animal behaviour and may result in health problems and product quality issues. The EU and China are facing a similar challenge, though not to the same extent. Efforts to maximise production and ensure product safety often involve overuse of anti-microbial drugs in farm animals either in veterinary treatment, or for growth-promoting purposes in those countries where they are allowed. Drug residues may accumulate in animal products and the environment, lead to food quality issues and constitute a risk for consumers. Welfare and environmentally-friendly production systems may improve animals' immunity and health conditions, and reduce veterinary drug use, in combination with other measures such as good husbandry practices and biosecurity. The EU has an increasingly active policy on improving animal welfare and fighting the threat of anti-microbial resistance. As China is seeing high levels of veterinary drug use in increasingly intensive production systems, it has an interest in cooperating with the EU on strategies to make those systems more sustainable.Scope:
Focusing on monogastric species in confined intensive systems, the proposed research activities should assess the links between livestock welfare and health, the underlying factors, the related use of anti-microbial drugs and the subsequent presence of residues in products and their spread into the environment. They should in particular address immunity and health, biosecurity measures and residue detection. The activities should develop possible means, including tools, methods and schemes, by which more welfare-friendly production systems can help improve health and reduce the use of veterinary drugs. The proposed activities should, where possible, measure the potential impact of the proposed measures, including the socio-economic aspects and the scope for establishing schemes (standard-setting, management, policy, monitoring and verification components).
The Commission considers that proposals requesting a contribution from the EU of up to EUR 5 million would allow this specific challenge to be addressed properly. Nonetheless, this does not preclude the submission and selection of proposals requesting other amounts. Contributions for Chinese participants will come in addition and will be made available by China.Expected Impact:
- welfare-friendly production systems (housing, equipment, technology) to improve farm animal immunity, health and welfare effectively;
- reduced veterinary drug use at farm level and reduced residue in animal products in order to improve food safety;
- improved biosecurity at farm level; and
- contribution to the development of common legislation and standard-setting in the EU and China
Topic conditions and documents
Please read carefully all provisions below before the preparation of your application.
- List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to Australia, Brazil, Canada, China, Hong Kong & Macau, India, Japan, Republic of Korea, Mexico, Russia, Taiwan).
- Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme [, with the following exceptions]:
3.2 Submission and evaluation process: Guide to the submission and evaluation process
- Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
Information on the outcome of two-stage evaluation:
For stage 1: maximum 3 months from the deadline for submission.
For stage 2: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
- Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 General MGA -Multi-Beneficiary
Annotated Grant Agreement
- Additional provisions:
Horizon 2020 budget flexibility
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply.
Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.
- Open access must be granted to all scientific publications resulting from Horizon 2020 actions.
- Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
- The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
- Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
- Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
- Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs.
- Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
- The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
- Further information on the Open Research Data Pilot is made available in the H2020 Online Manual.
- Additional documents
- H2020 Work Programme 2016-17: Introduction
- H2020 Work Programme 2016-17: Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy
- H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
- H2020 Work Programme 2016-17: General Annexes
- Legal basis: Horizon 2020 - Regulation of Establishment
- Legal basis: Horizon 2020 Rules for Participation
- Legal basis: Horizon 2020 Specific Programme
No submission system is open for this topic.
H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.
Participant Portal FAQ – Submission of proposals.
National Contact Points (NCP) - contact your NCP for further assistance.
Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.
IT Helpdesk- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
Ethics – for compliance with ethical issues, see the Participant Portal and Science and Society Portal
European IPR Helpdesk assists you on intellectual property issues
Partner Search Services help you find a partner organisation for your proposal
IMI Partner Search Tool helps you find a partner organisation for your proposal